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During the late phase of adenovirus infection, the major late promoter (MLP) controls the regulated expression of the
genes that encode most viral structural proteins. Recently, the region of the genome of mouse adenovirus type 1 (MAV-1),
predicted to contain the MLP, was sequenced and compared to that of the human virus MLP. The general organization of
the transcriptional elements of the putative MAV-1 MLP is similar to that of the human virus counterpart, with some interesting
differences. We wished to investigate the function of the predicted MLP of MAV-1 and to determine the significance of
the differences found in the MAV-1 MLP. To test the activity of the predicted MLP of MAV-1, both Northern blot and primer
extension analyses were performed on intracellular RNA isolated from cells infected with MAV-1. The results show that
late RNA can be detected 48 hr postinfection and increases up to 6 days p.i. Primer extension analysis revealed that the
major start sites of transcription are 28 and 31 nt downstream of the first T residue of the predicted TATA box. To
analyze the functional significance of the predicted transcriptional elements, a transient transfection system, using the
firefly luciferase gene controlled by the MAV-1 MLP sequence, was established. The predicted MLP sequence was capable
of directing luciferase gene expression, to a level some 60% of that of the human virus MLP. Mutations were created in
the inverted CAAT box, the SP1 site, and the TATA box, either singly or in combination. Each single-element mutation
causes a marked reduction in luciferase gene expression, with the SP1 mutation showing the greatest effect. Double
mutations were even more deficient, suggesting a level of functional redundancy among the various transcriptional elements.
Finally, the putative SP1-binding site was examined by gel mobility shift assay and shown to interact with purified SP1
protein specifically, supporting the functional significance of this transcriptional element. These findings contribute to a
better understanding of gene expression in MAV-1 and to its development as an appropriate model for the study of the
molecular basis of pathogenesis in a natural host animal. q 1997 Academic Press
cal similarity to the human adenoviruses but its patho-INTRODUCTION
genesis is not directly comparable to that of any one
Adenoviruses have been isolated from a variety of ver- human adenovirus serotype. It has adrenal and cardiac
tebrates in association with a correspondingly wide tropism, and infection of suckling mice by MAV-1 results
range of diseases. The molecular biology of a few of in a wasting disease followed by death (reviewed in Ishi-
the 49 human serotypes has been and continues to be bashi and Yasue, 1984). Adult mice recover from infection
investigated intensively. However, relatively little is but continue to shed the virus for up to 24 months follow-
known about the molecular basis of adenovirus patho- ing infection (Ishibashi and Yasue, 1984).
genesis. Understanding the molecular basis of adenovi- MAV-1 also shares molecular characteristics of other
ral pathogenesis has been hindered by the lack of an in adenoviruses such as inverted terminal repeats in the
vivo system to study the species-specific interaction of DNA (Temple et al., 1981) and association with a terminal
virus and host. Although there has been success in using protein (Larsen and Nathans, 1977). While the genome
cotton rats (Ginsberg et al., 1989) and hamsters (Hjorth of MAV-1 is somewhat smaller (31,000 bp) than that of
et al., 1988) to study in vivo pathogenesis of the human the human adenoviruses types 2 and 5 (Ad2/5) (36,000
adenoviruses, development of a model using an adenovi- bp), initial characterizations have demonstrated that the
rus in its natural host is desirable. The discovery of ade- genome organization of MAV-1 is similar to that of the
noviruses in the house mouse Mus musculus (Hartley human adenoviruses. Early regions 1A and 1B are lo-
and Rowe, 1960) suggests that they may be useful mod- cated at the left end of the genome, and early region 3
els to study molecular pathology in the natural host. is located toward the right end; all three transcription
Mouse adenovirus type 1 (MAV-1) was originally char- units are transcribed in the rightward direction (Ball et
acterized as an adenovirus based on its serological prop- al., 1988, 1989; Beard et al., 1990; Raviprakash, 1989).
erties (Hartley and Rowe, 1960). MAV-1 has morphologi- Early region 4 (E4) of MAV-1 is transcribed in the leftward
direction and is located at the right end of the genome,
as is the case for human adenoviruses (Ball et al., 1991;1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (212) 305-1468. E-mail: csyl@columbia.edu. Kring et al., 1992). Late regions corresponding to the IVa2
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this observation must be confirmed and extended to gain




Monolayers of mouse 3T6 cells in 10-cm dishes,
grown to confluency in Dulbecco’s modified Eagle’s me-
dium with 10% supplemented calf serum (Hyclone),
were infected with MAV-1 at a m.o.i. of 5 PFU per cell
or mock-infected. Total RNA was isolated from both
FIG. 1. A comparison of the DNA sequence of the predicted MLP of samples using RNA STAT-60 (Tel-Test ‘‘B’’ Inc.,
MAV-1 with that of the MLP of human adenovirus type 5. The figure is Friendswood, TX) as described by the manufacturer,modified from one published previously (Song et al., 1996). The ele-
based on the one-step procedure of Chomczynski andments known to play a role in the function of the Ad5 MLP are identified
Sacchi (1987). The RNA (10 mg per sample) was re-in boldface below the alignment, and the equivalent sequences in both
viruses are underlined. solved on a 1% agarose gel and transferred to a nitrocel-
lulose membrane (Schleicher & Schuell). The mem-
brane was prehybridized for 1 hr, hybridized overnight
gene, the L3 family of pVI, hexon, and endoproteinase in the presence of [a-32P]dATP-labeled random-primed
genes, and the L4 family of 100- and 33-kDa genes have MAV-1 pVI gene probes at 657, washed, dried, and ex-
been sequenced and show similarity to those found in posed to a Fuji RX film, using standard conditions (Sam-
human adenoviruses (Kring and Spindler, 1990; Song et brook et al., 1989).
al., 1995; Weber et al., 1994; Cai et al., 1992; Cauthen
and Spindler, 1996). Primer extension
By convention, the adenovirus life cycle is divided into
two phases, early and late, which are separated by the Monolayers of mouse 3T6 cells in 10-cm dishes were
onset of viral DNA replication and characterized by the infected with MAV-1 at a m.o.i. of 5 PFU per cell or mock-
expression of specific subsets of the viral genome. Dur- infected. Total RNA was isolated from both samples as
ing the late phase of infection, the major late promoter described above. Equivalent amounts of RNA (20 mg per
(MLP) of adenovirus controls the transcription of a major sample) were hybridized to a 5*-end-labeled primer com-
late RNA transcript, which is processed into five major plementary to the putative first leader of the predicted
families of mRNA, and these encode most of the viral MAV-1 MLP. The primer used was as follows: 9604-L1
structural proteins. Unlike the early regions, the late tran- (MLP-antisense), 5* CTT CTT GTG AGA ACA CAA GGC-
scription unit and its regulation in MAV-1 are not well 3*. The 5* nucleotide of the primer is located 83 bp down-
characterized. The region of the genome predicted to stream from the first T of the TATA box (see Fig. 6). The
include the MLP of MAV-1 has been sequenced recently duplex was extended by using an avian myeloblastosis
(Song et al., 1996). The overall organization of the putative virus reverse transcriptase (Promega) as described in
promoter is similar to that of the human viruses (Fig. 1), in detail previously (Reach et al., 1990). Extended DNA
that it contains sequences corresponding to an inverted products were separated on a 6% polyacrylamide se-
CAAT box, a TATA box, and at least one of the down- quencing gel.
stream elements, DE1. However, the USF-binding site,
conserved in all other mammalian viruses (Song et al., Construction of MLP–luciferase plasmids
1996), is missing and is replaced by a sequence with
similarity to an SP1 site. In addition, there was no evi- To make the MAV-1 MLP–luciferase reporter con-
dence for an initiator sequence at an appropriate dis- struct, a 487-bp HindIII– XmnI MAV-1 MLP fragment was
tance from the TATA box. However, these predictions subcloned from pBS59, a pBR322-derivative plasmid con-
are derived purely from the sequence comparison with taining a PCR-amplified MAV-1 MLP region, into the
the human adenovirus MLP. Thus it was important to pGL2-basic reporter plasmid (Promega) to generate
establish that the predicted MLP is used in a viral infec- pBS75. To make the human adenovirus MLP–luciferase
tion at late times and that the transcriptional elements reporter construct, a 453-bp HindIII– XhoI Ad MLP frag-
identified by sequencing contribute to its function. Initial ment was subcloned from pMR2, a pBR322-derivative
experiments using ribonuclease protection assays with plasmid containing 1 to 9533 bp of human adenovirus
RNA isolated from MAV-1-infected cells suggested that genome, into the pGL2-basic reporter plasmid to gener-
ate pBS74.the predicted MLP is indeed used (Song et al., 1996), but
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Site-directed mutagenesis added to 20 ml of room-temperature cytosol extract by
automatic injection, and the relative light units for the
Mutations in the MAV-1 MLP were created by PCR firefly luciferase were recorded with a luminometer
using Taq DNA polymerase and the PCR Core Kit (Boeh- (Berthold, Lumat LB9501). Then 100 ml of room tempera-
ringer-Mannheim) as described by the manufacturer. ture Stop & Glo Reagent was added by automatic injec-
Briefly, two complementary oligonucleotides were de- tion, and the relative light units for the Renilla luciferase
signed for each mutation. First, two separate PCRs were were recorded. The MLP expression was corrected for
performed using a MLP-containing plasmid that contains expression of Renilla luciferase from the pRL-CMV plas-
SP6 and T7 RNA polymerase promoters flanking the mid (Promega). Most samples were assayed in triplicate.
MLP. The T7 primer and one of the two complementary
oligonucleotides were used as PCR primers in one reac-
Gel mobility shift assaytion, and the SP6 primer and the other oligonucleotide
were used in the other reaction. Then the PCR products The single-stranded oligonucleotides containing the
were used as templates in the second PCR using the T7 putative SP1-binding site of the predicted MAV-1 MLP
and SP6 primers. The oligonucleotides used in the PCR were hybridized by heating to 657 in 100 mM NaCl –1
mutagenesis were as follows: 9609-TA1 (to mutate the mM EDTA and slowly cooling to 307, and phosphorylated,
TATA box, MLP-sense), 5*-GTT CTC TgT AgA AAG GGG using 10 U of polynucleotide kinase and 50 mCi of [g-
CG-3*; 9609-TA2 (to mutate the TATA box, MLP-anti- 32P]ATP in a 20-ml reaction. The phosphorylated oligonu-
sense), 5*-CGC CCC TTT cTA cAG AGA AC-3*; 9609-SP1 cleotides were purified from the unincorporated [32P]ATP
(to mutate the SP1-binding site, MLP-sense), 5*-TAA AAA by elution from NAP-5 columns (Pharmacia). The labeled
GaG tGT aGT CAA CA-3*; 9609-SP2 (to mutate the SP1- duplex oligonucleotides were added to a total volume of
binding site, MLP-antisense), 5*-TGT TGA CtA CaC tCT 20 ml containing 4 ml of 51 buffer [50 mM Tris–HCl (pH
TTT TA-3*; 9609-CA1 (to mutate the CAAT box, MLP- 7.5), 250 mM NaCl, 5 mM EDTA, 20 mM DTT, 1 mg/ml
sense), 5*-GAA ATT TGc TaG cCT TAA AA-3*; 9609-CA2 bovine serum albumin, 25% glycerol]. Purified human SP1
(to mutate the CAAT box, MLP-antisense), 5*-TTT TAA protein (Promega) was added to the reaction mix and
GgC tAg CAA ATT TC-3*. The mutated nucleotides are incubated for 15 min at room temperature. For competi-
shown in lowercase. The cycling conditions were as fol- tion assays, SP1 was preincubated for 5 min with com-
lows: 1 min at 947, 30 cycles of (1 min at 947, 2 min at petitor oligonucleotide, prior to the addition of the labeled
557, and 3 min at 727), and 7 min at 727. Mutations were oligonucleotide. Electrophoresis was performed through
confirmed by restriction enzyme digestion and by se- a 6% nondenaturing polyacrylamide gel to separate
quencing performed with dye terminators on an ABI 373A bound from unbound probe. The gel was dried and ex-
machine in the Columbia Cancer Center DNA facility. posed to Fuji RX film. The oligonucleotides used were
Oligonucleotides were purchased from Genosys. as follows: 9411-MSP1 (the putative SP1-binding site in
the MAV-1 MLP, MLP-sense), 5*-AAA TTA AAA AGG GCGTransient transfections and luciferase assays
TGG TCA ACA ACT-3* and its complement 9411-MSP2
and nonspecific competitor 5*-GAT CAC TCG GGC GCGAll cell lines were transfected by the calcium phos-
phate precipitation method (Graham and van der Eb, CA-3* and its complement.
Oligonucleotides were purchased from Oligos Etc.,1973). Mouse 3T3 cells, mouse 3T6 cells, or human A549
cells were seeded in 35-mm-diameter tissue culture from Genosys, or from the oligonucleotide-synthesizing
facility at Columbia University Comprehensive Cancerdishes (Falcon) at approximately 40 to 50% confluence
in Dulbecco’s modified Eagle’s medium with 10% supple- Center.
mented calf serum (Hyclone) and allowed to grow over-
night. One milligram of each plasmid was added to each
RESULTS
plate. Following incubation at 377 for 12 hr, cells were
boosted with 20% glycerol –saline, washed twice with 11 Accumulation of late viral mRNAs in infected cells
Hanks’ balanced salt solution (Gibco BRL), and overlaid
with Dulbecco’s modified Eagle’s medium. Cells were The region of the MAV-1 genome predicted to contain
the MLP was sequenced recently, and ribonuclease pro-harvested 24 to 36 hr later, and luciferase activity was
assayed using the Dual-Luciferase Reporter Assay Sys- tection assays suggested that it was functional in vivo
(Song et al., 1996). To confirm its functionality and to gaintem (Promega) as described by the manufacturer. Briefly,
at the time of harvesting, cells were washed with cold a greater understanding of its temporal expression, the
accumulation of major late mRNAs in infected cells wasPBS, lysed with 200 to 400 ml of lysis buffer (Promega),
and scraped into 1.5 ml Eppendorf tubes. Nuclei were measured by Northern blot analysis. Total cellular RNA
was isolated 4 and 6 days after infection or mock-infec-removed from the extracts by pelleting at maximum
speed for 5 min and discarded. For each sample, 100 ml tion, separated on a 1% agarose/formaldehyde gel, and
transferred to nitrocellulose. The blot was probed withof room-temperature Luciferase Assay Reagent II was
AID VY 8677 / 6a3f$$$$82 07-18-97 10:28:05 vira AP: VY
112 SONG AND YOUNG
cells infected for 72 hr and from mock-infected cells.
Initial attempts used DNA primers located in the pre-
dicted pVI and hexon genes, but they were uniformly
unsuccessful. However, subsequent successful analy-
ses used a primer with its 5* end located 83 bp down-
stream from the first T residue of the predicted TATA box
(Fig. 1). Two prominent species of extension products 56
and 53 nucleotides long were detected only in infected
cells (Fig. 3A). Since the 5* end of the primer is the
second nucleotide (G) of the splice donor site (AGGT),
predicted from the previous ribonuclease protection
assays (Song et al., 1996), the 56-nucleotide species rep-
resents extension products complementary to RNAs with
a start site at the A residue 28 bp downstream of the first
T of the predicted TATA box. The 53-nucleotide species
corresponds to RNAs with a start site at the T residue
31 bp downstream of the first T residue. This heterogene-
ity of transcription initiation will be examined further un-
der Discussion. As mentioned above, primer extension
analysis was also used to investigate the temporal ex-FIG. 2. Analysis of MAV-1 late RNAs. Total RNA extracted from cells
pression pattern of the MLP. Total cellular RNA was iso-infected with MAV-1 for 4 and 6 days was analyzed on a Northern blot
as described under Materials and Methods. The blot was probed with lated from infected cells at 6, 24, 48, and 72 hr postinfec-
labeled DNA from the predicted pVI gene. Infection (/) and mock tion and from mock-infected cells at 6 hr. As shown in
infection (0) and the time of cell harvesting are shown at the top of Fig. 3B, the expression of MLP-specific RNA is first de-
the figure. The sizes of ribosomal RNAs are indicated on the right.
tected at 48 hr postinfection and cannot be seen at either
6 or 24 hr. A 20-fold longer exposure of the equivalent
gel did not reveal any extension products at the 24-hrlabeled DNA from the pVI gene. As shown in Fig. 2,
RNA sequences hybridizing to the pVI gene DNA can be
detected in infected cells 4 days postinfection, and the
levels increase at Day 6 (lanes 2 and 4). Subsequent
analyses with primer extension assays (see Fig. 3B)
showed that late RNA could be detected first at 48 hr
postinfection, a considerable delay compared with an
equivalent human virus infection. These results suggest
that the MAV-1 MLP is active in infected cells late in the
infectious cycle.
The predicted size of the MAV-1 pVI mRNA, assuming
that it forms the first species in the 3* coterminal L3
family of mRNAs, is at least 4.2 kb (Song et al., 1995;
Weber et al., 1994; Cai et al., 1992) and probably greater
than 4.5 kb depending on the number of nucleotides
included in the untranslated leader and the poly(A) tail.
The size of the lower hybridizing species on the formalde-
hyde gel is somewhat larger than the 28S ribosomal
FIG. 3. Primer extension analysis of 5* ends of MAV-1 late RNAs.marker, whose size is 4.7 kb. The origin of the larger
Total RNA was isolated from 3T6 cells infected with MAV-1 or mock-species is unknown.
infected, and primer extension analysis was performed as described
under Materials and Methods. The primer was a 5*-end-labeled oligo-
The predicted major late promoter of MAV-1 is nucleotide complementary to the putative first leader of the predicted
MAV-1 MLP: 5*-CTT CTT GTG AGA ACA CAA GGC-3*. The 5*-endfunctional in vivo
nucleotide of the primer is located 83 bp downstream from the first T
of the TATA box (see Fig. 6). (A) RNA was isolated from 3T6 cells mock-Previous studies suggested the overall similarity of
infected and infected with MAV-1 for 72 hr. Dideoxy sequence reactionsthe MLP of MAV-1 to its human viral counterpart, and a
are shown as a size standard. The numbers on the right indicate theribonuclease protection assay suggested possible posi-
major start sites. (B) Time course of MAV-1 late gene expression. RNA
tions for transcription initiation and splicing (Song et al., was isolated from 3T6 cells at 6, 24, 48, and 72 hr after infection. The
1996). To confirm the previous results, primer extensions upper and lower panels are from exposures for 9 hr and 7.5 days,
respectively.were performed on total cellular RNAs obtained from
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TABLE 1 MLP from human adenovirus type 5 directing the lucifer-
ase gene.Mutations in the Putative Elements of the MAV-1 MLP
The various MLP–luciferase constructs were trans-
Mutation in CAAT box SP1-binding site TATA box fected together with a control expression vector pRL-
CMV expressing Renilla luciferase, into mouse 3T3 cells,
None (wild-type) ATTGG GGGCGTGG TATAAAA mouse 3T6 cells, or human A549 cells by the calcium
TATA box TgTAgAA
phosphate precipitation method. Cells were harvestedSP1 site GaGtGTaG
36 to 48 hr after transfection, extracts were prepared,CAAT box cTaGc
TATA: :SP1 GaGtGTaG TgTAgAA and luciferase activity was assayed using the Dual-Lucif-
TATA: :CAAT cTaGc TgTAgAA erase Reporter Assay System. As shown in Figs. 4A and
SP1 : :CAAT cTaGc GaGtGTaG 4B, both the human adenovirus and the mouse adenovi-
rus MLPs are functional in either human A549 cells orNote. Mutations are indicated in lowercase.
mouse 3T6 cells, but the mouse adenovirus MLP was
about twofold less active than the human adenovirus
MLP in both cell types. As shown in Figs. 4C and 4D, atime point, suggesting that the MLP is not expressed at
mutation in any one of the putative transcription elementsthat time.
caused a significant reduction in promoter activity. Inter-These results are in complete agreement with those
estingly, the mutation in the possible SP1-binding sitefrom the previous ribonuclease protection assays and
showed the greatest reduction in promoter activity. Onetogether suggest that the predicted MLP of MAV-1 is
interpretation of this observation is that in the MLP offunctional in vivo, with a precisely defined set of start
MAV-1, the SP1-binding site is more important than eithersites.
the TATA box or the CAAT box. Any combination of muta-
tions in the elements showed a greater defect in pro-A genetic analysis of the predicted transcription
moter function than a mutation in any single element,elements in the MAV-1 MLP
implying possible functional interactions between the
transcription factors that bind to the elements.The organization of the putative MLP of MAV-1 is simi-
lar to the human virus counterpart in that there are se- Taken together, these results show that the MLP of
MAV-1 is functional in transient assays and that the TATAquences corresponding to TATA and CAAT boxes (Fig.
1), but there is a possibility that an SP1-binding site re- box, SP1-binding site, and CAAT box are important in
the function of the MAV-1 MLP, at least in this artificialplaces the conserved USF-binding site found in all other
mammalian adenovirus MLPs. Although the results de- context.
scribed above show that the MLP of MAV-1 is functional
in infected mouse cells (Fig. 3), this does not address The putative SP1-binding site in the MAV-1 MLP
the question of whether any or all of the suggested tran- binds the SP1 protein specifically
scription elements are necessary for MLP function. We
wished to determine the functional significance of each The comparison of the predicted MAV-1 MLP with the
human adenovirus MLP shows that the proximal up-of the transcription factor-binding sites found in the MAV-
1 MLP. One approach would be to build viruses in which stream promoter element (UPE) is absent and that the
sequence at the equivalent position bears a resemblancemutations in the elements could be analyzed in the natu-
ral genomic context, using methods similar to those used to an SP1-binding site, GGGCGTGG, in which the under-
lined T is different from the canonical G (Briggs et al.,previously to analyze the human virus MLP (Reach et
al., 1990). Despite recent progress in the genetics and 1986). To investigate the functional significance of the
putative SP1-binding site, a gel mobility shift assay wasmolecular biology of MAV-1 (Beard and Spindler, 1996;
Smith et al., 1996), a simple genetic system is not avail- performed with purified human SP1 protein. An oligonu-
cleotide containing the putative binding site was incu-able at this moment for constructing an MLP-mutant vi-
rus. Therefore we pursued an alternative approach, bated with SP1 protein and electrophoresed on a native
polyacrylamide gel (Fig. 5). As shown in lane 2, the mobil-namely a transient expression assay, to determine the
importance of each of the transcription factor-binding ity of the probe was reduced, with the appearance of a
slower-migrating band. SP1 protein incubated with a 50-sites. Plasmid constructs were created in which the ex-
pression of a luciferase reporter gene was directed by fold molar excess of unlabeled oligonucleotide con-
taining the putative SP1-binding site markedly reducedthe wild-type or mutant forms of the MAV-1 MLP (see
Materials and Methods for details). Site-directed muta- the appearance of the slower-migrating band (lane 3),
whereas competition with an unrelated oligonucleotidegenesis was performed by PCR to create mutations in
each element or to create a combination of mutations in containing the ZF5-binding site (Kaplan and Calame,
1997) did not eliminate the slower-migrating band (lanethe elements (Table 1). As a comparison, the same clon-
ing strategy was used to create a plasmid with the known 4). Although the affinity of purified SP1 for the putative
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FIG. 4. The expression of human Ad5 and wild-type and mutant MAV-1 MLPs in human and mouse cells. Reporter plasmids containing the firefly
luciferase linked with the appropriate MLP were cotransfected with a control plasmid expressing Renilla luciferase into human A549 cells, mouse
3T6 cells, or mouse 3T3 cells. Most transfections were assayed in triplicate, and individual samples were analyzed using the Dual-Luciferase kit
(Promega). (A) Expression of the human Ad5 MLP (column 1) and mouse adenovirus MLP (column 2) in human A549 cells. (B) Expression of hMLP
(column 1) and mMLP (column 2) in mouse 3T6 cells. (C) Expression of mutant mMLPs in human A549 cells. Column 1, WT; column 2, mutant
TATA box; column 3, mutant SP1; column 4, mutant CAAT box. (D) Expression of single- and double-mutant mMLPs in mouse 3T3 cells. The columns
are as follows: 1, WT; 2, mutant TATA; 3, mutant SP1; 4, mutant CAAT box; 5, TATA: :SP1 mutant; 6, TATA: :CAAT mutant; 7, SP1: :CAAT mutant.
binding site in the MAV-1 MLP was not examined in specifically interacts with the SP1 protein and further
support the idea that the site is a functional transcrip-detail, it was noticed that the efficiency of competition
by the homologous sequence was considerably greater tional element.
than that shown by a consensus SP1 duplex oligonucleo-
tide provided by the supplier of the purified protein (data DISCUSSION
not shown), suggesting that the site in the MAV-1 MLP
The MLP of human adenovirus is one of the mostis a high-affinity site. Together, these results suggest
studied models for eukaryotic transcription. The require-that the putative SP1-binding site in the MLP of MAV-1
ments for specific cis-acting sequences have been ex-
amined, using in vitro transcription and plasmid-borne
transfection assays, as well as at ectopic sites in the
viral genome (reviewed in Reach et al., 1990, 1991).
These studies have defined cellular-factor-binding sites
important to promoter function under the experimental
conditions employed. More recently an experimental sys-
tem in which mutations in the MLP could be examined
in their correct viral context was developed (Brunet et
al., 1987; Reach et al., 1990). The latter studies suggested
a marked redundancy of function either between up-
stream activating elements (Reach et al., 1990) or be-
tween basal elements (Lu et al., 1997).
In contrast to the detailed information available about
FIG. 5. Retardation of a duplex oligonucleotide containing the puta- the human virus MLPs, very little is known about the
tive SP1-binding site by purified SP1 protein. The additions to the reac- structure or function of the major late promoter from ade-
tion mix are indicated above the gel. Lane 1 shows the migration of
noviruses of other species. Previous studies showed thethe free probe, and lane 2 shows retardation by incubation with purified
overall similarity of the predicted MLP of MAV-1 to itsSP1 protein. Competition was performed either with cold-specific oligo-
nucleotide (lane 3) or with a nonspecific oligonucleotide (lane 4). human viral counterpart and identified the possible posi-
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FIG. 6. A summary of the structure of the MAV-1 MLP and the positions of transcriptional signals. The sequence from 078 to /141 is shown.
Sequences shown in boldface represent the transcription elements supported by the transfection data of Fig. 4, and the transcription start and
splice sites deduced from the primer extension data (Fig. 3) and previous ribonuclease protection assays (Song et al., 1996). Numbers above the
sequence indicate the 5* nucleotide of the respective transcription elements or the positions of the 3* nucleotide of the splice donor sites, measured
from the major proximal start site (/1). The asterisks represent the exon–intron boundaries of the two adjacent splice donor sites. The position
and sequence of the single-stranded oligonucleotide used in the primer extension assays are indicated by underlining.
tions for transcription initiation and splicing, using a ribo- box. The longer exposure shown in Fig. 3B shows that
there is some further heterogeneity of start sites, alsonuclease protection assay (Song et al., 1996). In this
study, we have investigated the structure and function seen previously with ribonuclease protection assay. The
apparent lack of the initiator element in the MLP of MAV-of the predicted MLP of MAV-1 in greater detail. The
conclusions from the combined analyses are summa- 1 may explain this heterogeneity of transcription initia-
tion. Alternatively, we could imagine that the replacementrized in Fig. 6.
Initial Northern blot analysis (Fig. 2) showed that late of the UPE element with the SP1-binding site in the MAV-
1 MLP might contribute to the heterogeneity of transcrip-RNAs accumulated in MAV-1-infected cells 4 to 6 days
postinfection. This relatively late accumulation was con- tion initiation, assuming that there is a cooperative inter-
action of the USF at the UPE element with a transcriptionfirmed by temporal analysis using a primer extension
assay (Fig. 3B), which showed that late RNA could not factor at the basal element near the start site, as sug-
gested from genetic analysis of the human virus MLPbe detected at 24 hr postinfection, but could be detected
easily at 48 hr and increased from 48 to 72 hr. These (Lu et al., 1997). Regardless of the interpretation of the
heterogeneity of start sites, the primer extension resultsRNA accumulation data are consistent with the timing of
one-step replication cycles, in which newly made virus demonstrate that the predicted MLP of MAV-1 is func-
tional in infected cells in vivo.appears between 24 and 36 hr postinfection (Spindler,
personal communication). The primer extension assays Primer extension assays, using primers derived from
the predicted pVI or hexon genes, were unsuccessful,(Fig. 3) confirm the functionality of the predicted MAV-
1 MLP, first suggested by the preliminary ribonuclease despite multiple attempts and varying reaction condi-
tions. One possibility for this failure may be that theprotection assays. In the current study, we designed a
primer complementary to the predicted leader 1 region, untranslated leader region of MAV-1 major late RNAs is
more extensive than the equivalent tripartite leader fromwith the 5* end of the primer located 83 bp downstream
from the first T residue of the predicted TATA box. Two the human virus MLP, which, despite its predicted com-
plex secondary structure (Zhang et al., 1989), can beprominent species of extension products, 56 and 53 nu-
cleotides long, were found. The 56-nucleotide species analyzed by primer extension (Brunet et al., 1987). The
MAV-1 primers might be located far downstream fromcorresponds to transcripts with a start site at the A resi-
due 28 bp downstream of the first T residue of the pre- the predicted 5* terminus of the RNA and might not be
extendible through the whole of the leader region. Thedicted TATA box. The other extension product, a 53-nu-
cleotide species, corresponds to transcripts with a start complete sequence of the MAV-1 genome has recently
been determined (Spindler, personal communication),site at the T residue 31 bp downstream from the first T
residue of the predicted TATA box. Both the 56- and and it will be interesting to see if potential exons corre-
sponding to human virus late leader 2 and leader 3 canthe 53-nt products are completely consistent with the
previous ribonuclease protection results (Song et al., be identified.
The general organization of the MLP of MAV-1 is simi-1996), and together they support the interpretation that
the start sites are 28 and 31 nt downstream of the TATA lar to that of the human adenovirus counterpart (Fig. 1).
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The TATA box and CAAT box were found in both the slowly, shows very poor cytopathic effect, and produces
very low titers of viral yields when infecting productivehuman and the mouse virus MLPs, and equivalent se-
quences can be seen in all adenoviruses from mamma- cell lines such as 3T3, 3T6, or L cells, compared with
human virus infection of cell lines such as A549. Second,lian species and from the avian CELO virus (Chiocca et
al., 1996), suggesting both a long evolutionary history as discussed above, comparison of the MAV-1 MLP se-
quence with the human virus MLP suggests that theand functional importance. Previous genetic data have
established the importance of these two elements in the initiator element and one of the two downstream ele-
ments (DE2) are not present in the mouse virus promoterhuman virus MLP, and the transient assays strongly sug-
gest that they are both important in the functioning of (Song et al., 1996). This seemingly ‘‘poor’’ promoter might
contribute to inefficient expression of the late genes thatthe MAV-1 MLP (Figs. 4C and 4D).
The major differences between the human virus MLP are required for virus assembly. However, this apparent
lack of transcriptional element redundancy must beand the MAV-1 MLP are the apparent lack of an initiator
element (INR) around the start site of transcription, the treated with caution, because the elements may have
coevolved with their cognate binding factors, so that theyreplacement of the conserved USF-binding site by a po-
tential SP1-binding site, and the absence of the second are no longer easily recognizable by sequence analysis
alone. In this regard, it should be pointed out that adownstream element DE2. The MLP of human adenovi-
rus has an initiator element (CTCACTCTC), in which the sequence nearly identical to the human virus element
DE1, which binds a heterodimer of the adenovirus IVa2underlined A residue is the start site (Smale and Balti-
more, 1989), which conforms to the consensus PyPy- protein and perhaps the L1 52- 55-kDa protein (Gustin
et al., 1996), can be easily recognized in the MAV-1 se-AN(A/T)PyPy (Javahery et al., 1994). Recent evidence
shows that the INR of the human adenovirus MLP has quence, while the DE2a element which also binds a het-
erodimer is absent. The DE2b element, which binds aan important role in transcription initiation in vivo (Lu et
al., 1997). If it is true that the MAV-1 MLP lacks a function- homodimer of the IVa2 protein (Tribouley et al., 1994;
Lutz and Kedinger, 1996), cannot be recognized in theing INR, it may help to explain the heterogeneity of start
sites seen in the primer extension assays, as discussed MAV-1 sequence. Biochemical analysis of DNA binding
of the MAV-1 IVa2 protein to the downstream MLP regionabove. Whether or not the lack of an INR plays an im-
portant quantitative role in transcription initiation remains will help to resolve whether such elements exist in the
mouse virus.to be determined.
The upstream promoter element (UPE), which binds As a final point, it is not known if the relatively poor
replication in cell culture is reflected in the natural hostthe helix–loop–helix activator USF (Sawadogo and
Roeder, 1985), plays a very important role in the human animal, nor if the genotype of the mouse, which affects
the pathological outcome (Guida et al., 1995; Kring et al.,virus MLP (Reach et al., 1990, 1991), but MAV-1 MLP has
a putative SP1-binding site at the equivalent position. 1995), also affects expression from the MLP. The ability
to compare effects in cell culture with those in the animalThus it was of great interest to see if the SP1 site replace-
ment is functionally important. As shown in Fig. 5, the from which the cells were derived is one of the attractions
of the use of MAV-1 as an experimental system to studyputative SP1-binding site specifically interacts with puri-
fied SP1 protein, consistent with the idea that this site the molecular basis of pathogenesis.
binds SP1 in vivo. The functional significance of the SP1
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